Ebola Vaccination Using a DNA Vaccine Coated on PLGA‐PLL/γPGA Nanoparticles Administered Using a Microneedle Patch

Ebola DNA vaccine is incorporated into PLGA-PLL/γPGA nanoparticles and administered to skin using a microneedle (MN) patch. The nanoparticle delivery system increases vaccine thermostability and immunogenicity compared to free vaccine. Vaccination by MN patch produces stronger immune responses than intramuscular administration.

[1]  D. Cribbs,et al.  Delivery of a DNA Vaccine for Alzheimer’s Disease by Electroporation versus Gene Gun Generates Potent and Similar Immune Responses , 2012, Neurodegenerative Diseases.

[2]  F. Arnold,et al.  The future of cell culture-based influenza vaccine production , 2011, Expert review of vaccines.

[3]  A. Klibanov,et al.  Moisture-Induced Aggregation of Lyophilized DNA and its Prevention , 2006, Pharmaceutical Research.

[4]  A. Folgori,et al.  Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials , 2013, Expert review of vaccines.

[5]  C. Bréchot,et al.  Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors. , 2004, Journal of hepatology.

[6]  Richard Heller,et al.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  D. Swenson,et al.  Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections , 2008, Clinical and Vaccine Immunology.

[8]  John-Arne Røttingen,et al.  Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial , 2015, The Lancet.

[9]  Paula T Hammond,et al.  Polymer multilayer tattooing for enhanced DNA vaccination. , 2013, Nature materials.

[10]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. , 2011, Polymers.

[11]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[12]  D. Kaplan.  In vivo function of Langerhans cells and dermal dendritic cells. , 2010, Trends in immunology.

[13]  A. Kissenpfennig,et al.  Microneedle-mediated vaccine delivery: Harnessing cutaneous immunobiology to improve efficacy , 2012, Expert opinion on drug delivery.

[14]  Heinz Feldmann,et al.  Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus , 2009, Journal of Virology.

[15]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  R. Donnelly,et al.  Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success. , 2016, Current pharmaceutical design.

[17]  V. Apostolopoulos,et al.  Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[18]  S. Marshall,et al.  Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use. , 2016, Vaccine.

[19]  M. Fons,et al.  Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  M. Schroff,et al.  Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein Vaccine , 2014, PloS one.

[21]  Conor O'Mahony,et al.  Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  H. Sasaki,et al.  Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal. , 2011, Vaccine.

[23]  Sarsvatkumar Patel,et al.  Compression physics in the formulation development of tablets. , 2006, Critical reviews in therapeutic drug carrier systems.

[24]  T. Wu,et al.  Enhancement of DNA Vaccine Potency through Coadministration of CIITA DNA with DNA Vaccines via Gene Gun1 , 2008, The Journal of Immunology.

[25]  Michele A. Kutzler,et al.  DNA vaccines: ready for prime time? , 2008, Nature Reviews Genetics.

[26]  Chun-Hui Wang,et al.  Biodegradable Nanoparticles of mPEG-PLGA-PLL Triblock Copolymers as Novel Non-Viral Vectors for Improving siRNA Delivery and Gene Silencing , 2012, International journal of molecular sciences.

[27]  M. Prausnitz,et al.  DNA vaccination in the skin using microneedles improves protection against influenza. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Viness Pillay,et al.  Current advances in the fabrication of microneedles for transdermal delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[29]  M. Prausnitz,et al.  Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  J. Dye,et al.  Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector , 2010, Clinical and Vaccine Immunology.

[31]  R. Mumper,et al.  Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. , 2003, Journal of biotechnology.

[32]  Hsing-Wen Sung,et al.  Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. , 2009, Biomaterials.

[33]  S. Nakagawa,et al.  Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease , 2014, Journal of Neuroimmunology.

[34]  Alessandro Vespignani,et al.  Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. , 2015, Lancet. Infectious Diseases (Print).

[35]  R. Compans,et al.  Targeting the skin for microneedle delivery of influenza vaccine. , 2013, Advances in experimental medicine and biology.

[36]  M. Prausnitz,et al.  Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine , 2010, Gene Therapy.

[37]  Christopher Dye,et al.  Ebola vaccine--an urgent international priority. , 2014, The New England journal of medicine.

[38]  Mark R Prausnitz,et al.  Microneedle patches for vaccination in developing countries. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[39]  J. Matriano,et al.  Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.

[40]  M. Ameri,et al.  Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses , 2014, Pharmaceutics.

[41]  Amit Kumar,et al.  Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[42]  K. Okuda,et al.  Developments in Viral Vector-Based Vaccines , 2014, Vaccines.